Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Change in Cash (2022 - 2025)

Historic Change in Cash for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$7.6 million.

  • InflaRx's Change in Cash fell 19000.09% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.8 million, marking a year-over-year decrease of 36271.02%. This contributed to the annual value of $4.5 million for FY2024, which is 26720.28% up from last year.
  • According to the latest figures from Q3 2025, InflaRx's Change in Cash is -$7.6 million, which was down 19000.09% from -$9.9 million recorded in Q4 2024.
  • InflaRx's 5-year Change in Cash high stood at $19.2 million for Q2 2023, and its period low was -$28.3 million during Q2 2022.
  • Its 4-year average for Change in Cash is -$1.4 million, with a median of -$1.2 million in 2022.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 61619.02% in 2023, then skyrocketed by 28435.14% in 2024.
  • Quarter analysis of 4 years shows InflaRx's Change in Cash stood at -$1.2 million in 2022, then plummeted by 616.19% to -$8.8 million in 2023, then fell by 12.95% to -$9.9 million in 2024, then grew by 22.97% to -$7.6 million in 2025.
  • Its last three reported values are -$7.6 million in Q3 2025, -$9.9 million for Q4 2024, and $8.5 million during Q3 2024.